The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1746
January 19, 2026
View Complete Issue         Table of Contents 2019 
Issue 1746
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Sublingual Cyclobenzaprine (Tonmya) for Fibromyalgia
January 19, 2026 (Issue: 1746)
The FDA has approved Tonmya (Tonix), a sublingual tablet formulation of the skeletal muscle relaxant cyclobenzaprine, for treatment of fibromyalgia in adults. Cyclobenzaprine is available in immediate-release tablets and extended-release capsules...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1746
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.